Physician profile
Donald Behrmann
NPI 1841249711
$29,093.85
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,007 · 2020: $108 · 2021: $6,344 · 2022: $5,778 · 2023: $4,029 · 2024: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $16K · Food and Beverage: $18.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $15,838.66 |
| Food and Beverage | $18.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integrity Implants INC. Dba Accelus | $15,838.66 | 2023-2024 | Linesider |
| Integrity Implants INC. | $12,650.02 | 2019-2022 | Flarehawk, Linesider |
| Osteoremedies, LLC | $168.46 | 2022 | |
| Genesys Orthopedics Systems, L.L.C. | $142.77 | 2019-2020 | |
| Integra Lifesciences Corporation | $94.34 | 2019 | |
| Stryker Corporation | $69.94 | 2019 | |
| Zimmer Biomet Holdings, INC. | $56.08 | 2019-2020 | |
| Surgalign Spine Technologies, INC. | $55.27 | 2019 | |
| Heron Therapeutics, INC. | $18.31 | 2024 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Behrmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.